NOUVELLES UTILISATIONS DE L'OMALIZUMAB

Patent svizzer · CH720999 · Stritgà

Inscripziun en il register

Numer da publicaziun
CH720999
Numer da la dumonda
CH000601/2024
Gener
Patent svizzer
Status
Stritgà
Scrittira da patent
Dumonda, senza rapport da retschertga
Annunzià
04-06-2024
Publitgà
14-02-2025
Stritgà
09-10-2026
Motiv
Retratg
Classas IPC
A61K 39/395 (2006.01)
A61P 11/02 (2006.01)
A61P 11/06 (2006.01)
A61P 17/04 (2006.01)
A61P 37/08 (2006.01)
Classas CPC
A61K 39/39566 (2013-01-01)
A61P 11/02 (2018-01-01)
A61P 11/06 (2018-01-01)
A61P 17/04 (2018-01-01)
A61P 37/08 (2018-01-01)
Prioritad
EP EP23188544.3 28.07.2023
EP 24171754.5 22.04.2024
Scrittiras da patent
14.02.2025 A2
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-10-2026

    Retratg

    Status of protective title
    Active → Cancelled
    Cancellation date
    09.10.2026
    Cause for cancellation
    Application withdrawn

    Published in Swissreg on 09.10.2026

  2. 14-02-2025

    Specification status

    Specification status
    Non-published patent application → Patent application without search report
    Publication date
    14.02.2025

    Published in Swissreg on 14.02.2025

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

GENENTECH, INC.

Genentech, Inc.

1 DNA Way, South San Francisco,, California 94080-4990, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

Mathieu Paul-Léon Rigollet

68510 Uffheim, FR

Maria Chaikou

4056 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.